A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy
Clinical trial NCT03520491 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03520491
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2027-01-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.